Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016
Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013
Clinicopathologic Conference,Necrotizing Noninflammatory Myopathy Consistent with Exposure to Statins
NEJM 36:944-954, Case 7-2012, 2012
Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010
Neurologic Oral Manifestations Caused by a New Formulation of Mirtazapine
Neurol 65:333-334, Kling,A.,et al, 2005
A Double-blind Placebo-controlled Trial of Topiramate Treatment for Essential Tremor
Neurol 59:132-134, Connor,G.S., 2002
HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998
Acute Therapy for Cluster Headache with Sumatriptan:Findings of a One-Year Long-Term Study
Neurol 51:980-911, Gobel,H.,et al, 1998
Treatment with Oral 3, 4 Diaminopyridine Improves Leg Strength in Multiple Sclerosis Patients
Neurol 47:1457-1462, Bever,C.T.,et al, 1996
The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994
2', 3'-Dideoxycytidine (ddC) Toxic Neuropathy:A Study of 52 Patients
Neurol 43:358-362, Berger,A.R.,et al, 1993
Peripheral Neuropathy in a Patient Receiving Enalapril
Editorial, BMJ 305:13321992., , 1992
Astemizole-Induced Paresthesia
NEJM 323:684, Kaufman,H.S.,et al, 1990
Nitrofurantoin Polyneuropathy
Neurol 23:554-559, Toole,J.F.&Parrish,M.L., 1973